BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 14573593)

  • 21. Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.
    Ahmed I; Gesty-Palmer D; Drezner MK; Luttrell LM
    Mol Endocrinol; 2003 Aug; 17(8):1607-21. PubMed ID: 12738761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
    Xu KP; Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation.
    Han XB; Conn PM
    Endocrinology; 1999 May; 140(5):2241-51. PubMed ID: 10218977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cdelta, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation.
    Shah BH; Catt KJ
    Mol Pharmacol; 2002 Feb; 61(2):343-51. PubMed ID: 11809859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding.
    Pierce KL; Tohgo A; Ahn S; Field ME; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2001 Jun; 276(25):23155-60. PubMed ID: 11290747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone.
    Grosse R; Roelle S; Herrlich A; Höhn J; Gudermann T
    J Biol Chem; 2000 Apr; 275(16):12251-60. PubMed ID: 10766863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation.
    Milenkovic I; Weick M; Wiedemann P; Reichenbach A; Bringmann A
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1211-20. PubMed ID: 12601051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
    Xu KP; Ding Y; Ling J; Dong Z; Yu FS
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
    Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
    Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.
    Zhao Y; He D; Saatian B; Watkins T; Spannhake EW; Pyne NJ; Natarajan V
    J Biol Chem; 2006 Jul; 281(28):19501-11. PubMed ID: 16687414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.
    Uchiyama-Tanaka Y; Matsubara H; Mori Y; Kosaki A; Kishimoto N; Amano K; Higashiyama S; Iwasaka T
    Kidney Int; 2002 Sep; 62(3):799-808. PubMed ID: 12164862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
    Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
    Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metalloprotease-mediated HB-EGF release regulates EGF receptor transactivation in A431 cells under oxidative stress].
    Smirnova IS; Gonchar IV; Shatrova AN; Nikol'skiĭ NN; Burova EB
    Tsitologiia; 2010; 52(5):357-63. PubMed ID: 20586269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epoxyeicosatrienoic acid-stimulated phosphorylation of EGF-R involves the activation of metalloproteinases and the release of HB-EGF in cancer cells.
    Cheng LM; Jiang JG; Sun ZY; Chen C; Dackor RT; Zeldin DC; Wang DW
    Acta Pharmacol Sin; 2010 Feb; 31(2):211-8. PubMed ID: 20139904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Laburthe M
    J Biol Chem; 2004 May; 279(20):20927-34. PubMed ID: 15010475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors.
    Yan Y; Shirakabe K; Werb Z
    J Cell Biol; 2002 Jul; 158(2):221-6. PubMed ID: 12119356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades.
    Takenobu H; Yamazaki A; Hirata M; Umata T; Mekada E
    J Biol Chem; 2003 May; 278(19):17255-62. PubMed ID: 12611888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
    Yu Y; Zhang M; Zhang X; Cai Q; Zhu Z; Jiang W; Xu C
    J Exp Clin Cancer Res; 2014 Sep; 33(1):85. PubMed ID: 25261977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.
    Krieg T; Cui L; Qin Q; Cohen MV; Downey JM
    J Mol Cell Cardiol; 2004 Mar; 36(3):435-43. PubMed ID: 15010282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.